TY - JOUR
T1 - Solid-phase synthesis of chemotactic peptides using alpha-azido acids
AU - Tornøe, C W
AU - Sengeløv, H
AU - Meldal, M
PY - 2000/7
Y1 - 2000/7
N2 - Four chemotactic peptides, For-Met-Xxx-Phe-OMe, with an alpha,alpha-disubstituted amino acid at position 2 have been synthesized by the azido acid method [Meldal M, Juliano MA, Jansson AM. 1997. Azido acids in a novel method of solid-phase peptide synthesis. Tetrahedron Lett. 38: 2531-2534] on solid-phase, and were tested for biological activity. Dipropylglycine in the central position (Xxx) was found to be as active as the natural chemotactic peptide for chemotactic activity toward human neutrophils. Higher yields were obtained than previously reported solution-phase syntheses of chemotactic peptides, and EEDQ was used successfully for the difficult solid-phase formylation of amino groups.
AB - Four chemotactic peptides, For-Met-Xxx-Phe-OMe, with an alpha,alpha-disubstituted amino acid at position 2 have been synthesized by the azido acid method [Meldal M, Juliano MA, Jansson AM. 1997. Azido acids in a novel method of solid-phase peptide synthesis. Tetrahedron Lett. 38: 2531-2534] on solid-phase, and were tested for biological activity. Dipropylglycine in the central position (Xxx) was found to be as active as the natural chemotactic peptide for chemotactic activity toward human neutrophils. Higher yields were obtained than previously reported solution-phase syntheses of chemotactic peptides, and EEDQ was used successfully for the difficult solid-phase formylation of amino groups.
KW - Amino Acid Sequence
KW - Amino Acids/chemical synthesis
KW - Azides/chemical synthesis
KW - Calcium/metabolism
KW - Chemotactic Factors/chemical synthesis
KW - Drug Evaluation, Preclinical
KW - Humans
KW - In Vitro Techniques
KW - Magnetic Resonance Spectroscopy
KW - N-Formylmethionine Leucyl-Phenylalanine/metabolism
KW - Neutrophils/drug effects
KW - Oligopeptides/chemical synthesis
KW - Receptors, Formyl Peptide
KW - Receptors, Immunologic/drug effects
KW - Receptors, Peptide/drug effects
U2 - 10.1002/1099-1387(200007)6:7<314::AID-PSC255>3.0.CO;2-E
DO - 10.1002/1099-1387(200007)6:7<314::AID-PSC255>3.0.CO;2-E
M3 - Journal article
C2 - 10946996
SN - 1075-2617
VL - 6
SP - 314
EP - 320
JO - Journal of peptide science : an official publication of the European Peptide Society
JF - Journal of peptide science : an official publication of the European Peptide Society
IS - 7
ER -